Cargando…
The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies
BACKGROUND: As exercise exerts neurobiological and immunomodulatory effects, it might also act as a disease-modifying intervention in MS. However, a clear mechanistic link between exercise and disease-modifying effects in MS has yet to be established. OBJECTIVE: Establish recommendations for future...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637103/ https://www.ncbi.nlm.nih.gov/pubmed/37880953 http://dx.doi.org/10.1177/13524585231204453 |
_version_ | 1785146488186208256 |
---|---|
author | Rosenkranz, Sina C Ploughman, Michelle Hvid, Lars G Zimmer, P. Erickson, K. Stellmann, Jan-Patrick Centonze, Diego Friese, Manuel A |
author_facet | Rosenkranz, Sina C Ploughman, Michelle Hvid, Lars G Zimmer, P. Erickson, K. Stellmann, Jan-Patrick Centonze, Diego Friese, Manuel A |
author_sort | Rosenkranz, Sina C |
collection | PubMed |
description | BACKGROUND: As exercise exerts neurobiological and immunomodulatory effects, it might also act as a disease-modifying intervention in MS. However, a clear mechanistic link between exercise and disease-modifying effects in MS has yet to be established. OBJECTIVE: Establish recommendations for future mechanistic exercise studies in MS. METHODS: In regular meetings, members of the mechanisms of action group within the MoXFo (Moving eXercise research Forward in MS) initiative evaluated gaps of knowledge and discussed unmet needs in mechanistic MS research. RESULTS: We concluded that biomarkers assessed in translational studies in humans and animals are essential to decipher the underlying mechanisms of exercise in MS. Consequently, we defined clear definitions of different types of biomarkers examined in MS exercise studies and operationalized their use to align with the research question and optimal testing time points. Furthermore, we provide key considerations to improve the rigor of translational studies and defined minimal reporting criteria for animal studies. CONCLUSION: The resulting recommendations are intended to improve the quality of future mechanistic exercise studies in MS and consequently lead to a better understanding of therapeutic approaches. |
format | Online Article Text |
id | pubmed-10637103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-106371032023-11-14 The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies Rosenkranz, Sina C Ploughman, Michelle Hvid, Lars G Zimmer, P. Erickson, K. Stellmann, Jan-Patrick Centonze, Diego Friese, Manuel A Mult Scler Original Research Papers BACKGROUND: As exercise exerts neurobiological and immunomodulatory effects, it might also act as a disease-modifying intervention in MS. However, a clear mechanistic link between exercise and disease-modifying effects in MS has yet to be established. OBJECTIVE: Establish recommendations for future mechanistic exercise studies in MS. METHODS: In regular meetings, members of the mechanisms of action group within the MoXFo (Moving eXercise research Forward in MS) initiative evaluated gaps of knowledge and discussed unmet needs in mechanistic MS research. RESULTS: We concluded that biomarkers assessed in translational studies in humans and animals are essential to decipher the underlying mechanisms of exercise in MS. Consequently, we defined clear definitions of different types of biomarkers examined in MS exercise studies and operationalized their use to align with the research question and optimal testing time points. Furthermore, we provide key considerations to improve the rigor of translational studies and defined minimal reporting criteria for animal studies. CONCLUSION: The resulting recommendations are intended to improve the quality of future mechanistic exercise studies in MS and consequently lead to a better understanding of therapeutic approaches. SAGE Publications 2023-10-26 2023-11 /pmc/articles/PMC10637103/ /pubmed/37880953 http://dx.doi.org/10.1177/13524585231204453 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Papers Rosenkranz, Sina C Ploughman, Michelle Hvid, Lars G Zimmer, P. Erickson, K. Stellmann, Jan-Patrick Centonze, Diego Friese, Manuel A The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title | The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title_full | The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title_fullStr | The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title_full_unstemmed | The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title_short | The MoxFo initiative—Mechanisms of action: Biomarkers in multiple sclerosis exercise studies |
title_sort | moxfo initiative—mechanisms of action: biomarkers in multiple sclerosis exercise studies |
topic | Original Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637103/ https://www.ncbi.nlm.nih.gov/pubmed/37880953 http://dx.doi.org/10.1177/13524585231204453 |
work_keys_str_mv | AT rosenkranzsinac themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT ploughmanmichelle themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT hvidlarsg themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT zimmerp themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT ericksonk themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT stellmannjanpatrick themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT centonzediego themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT friesemanuela themoxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT rosenkranzsinac moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT ploughmanmichelle moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT hvidlarsg moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT zimmerp moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT ericksonk moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT stellmannjanpatrick moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT centonzediego moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies AT friesemanuela moxfoinitiativemechanismsofactionbiomarkersinmultiplesclerosisexercisestudies |